Senti Biosciences (NasdaqCM:SNTI) Update / Briefing December 09, 2025 08:00 AM ET Company ParticipantsKanya Rajangam - President, Head of R&D and Chief Medical OfficerNosha Farhadfar - Hematologist and Bone Marrow Transplant PhysicianTimothy Lu - CEO and Co-founderConference Call ParticipantsYale Jen - Senior Managing Director and Senior Biotech AnalystNone - AnalystGeulah Livshits - Senior Research AnalystOperatorHello, and welcome to the Senti Biosciences Senti 202 Clinical Update Conference Call and Webc ...